The Pharmacy Times® Chronic Kidney Disease Resource Center is a comprehensive resource for clinical news and expert insights on issues related to long-term disease of the kidneys leading to renal failure.
April 24th 2024
Iptocopan demonstrated superiority when treating patients with immunoglobulin A nephropathy and is the first drug to specifically target the alternative complement pathway.
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Advances in the Treatment of Metastatic Renal Cell Carcinoma: New Horizons in Targeted Therapies
1.0 Credit / Genitourinary Cancer, Oncology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Clinical Overview: Finerenone for Chronic Kidney Disease Associated With Type 2 Diabetes
May 24th 2022Approved by the FDA in 2021, finerenone is the only non-steroidal mineralocorticoid receptor antagonist that reduces the risk of renal disease progression and cardiovascular events in adults with type 2 diabetes mellitus-mediated chronic kidney disease.
Read More
FDA Accepts New Drug Application for Daprodustat as Treatment for Anemia, Chronic Kidney Disease
April 21st 2022The application is based on positive results from the ASCEND phase 3 clinical trial, assessing the efficacy and safety of daprodustat for the treatment of anemia from chronic kidney disease.
Read More
Daily Medication Pearl: Finerenone (Kerendia)
February 21st 2022Finerenone (Kerendia) is indicated to reduce the risk of sustained eGFR decline, end stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease.
Read More
Study: Limited Global Availability of Nutrition-Related Care for Patients with Kidney Disease
January 5th 2022A survey was administered electronically to key kidney care stakeholders in 182 International Society of Nephrology (ISN)-affiliated countries, with 88% responding and 97% answering the survey items related to kidney nutrition care.
Read More